About Annexon (ANNX)
Annexon, Inc. is a clinical-stage biopharmaceutical company focused on developing a pipeline of therapies for patients with classical complement-mediated disorders of the body, brain and eye. The Company’s pipeline is based on its platform technology... Read more
- USD2.52
- USD2.57
- USD2.41
- USD7.85
- -0.80%
- --
- 3.90M
- 1.37M
- 238M
- 1.29
- -64.00%
Stock News
3 hours ago
Stock market’s relentless rally threatens to turn into a ‘melt-up’. What’s next.
MarketWatch
5 hours ago
How Panama Canal plans to engineer over future of severe drought and climate change
CNBC
6 hours ago
30-year-old CEO left Wall Street, bought a 'stale' frozen yogurt chain—now it brings in $21 million a year
CNBC
7 hours ago
My husband and I ditched 90% of our stuff and lived in 10 cities in 2 years—we'd definitely do it again
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
